Figure 2From: A VELOUR post hoc subset analysis: prognostic groups and treatment outcomes in patients with metastatic colorectal cancer treated with aflibercept and FOLFIRI Overall survival according to treatment arms. (A) Better efficacy subgroup (B) Poorer efficacy subgroup.Back to article page